Torex Retail PLC
27 September 2006
Torex Retail Plc ('the Company')
Grant of Options
On 25 September 2006 the Board of the Company granted options over ordinary
shares of 1p each ('Ordinary Shares') at an option price of 40.5p per Ordinary
Share being the closing price for Ordinary Shares as at 22 September 2006 to 117
of the Company's employees in line with prior arrangements. These included
grants to the following directors of the Company:
Director Number of Options Granted No. of Ordinary Shares over which
options held following this
notification
Christopher Moore 300,000 8,109,000
Mark Pearman 150,000 4,400,000
Nigel Horn 150,000 1,100,000
Edwin Dayan 150,000 500,000
Michael Carrell 300,000 300,000
Marcus Leek 250,000 250,000
No consideration was paid for the grant of these new options, and the period
during which they are exercisable is 25 September 2009 to 25 September 2016.
27 September 2006
Enquiries:
Citigate Dewe Rogerson:
Ginny Pulbrook, Director: Tel: 020 7282 2945
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.